ToxStrategies is excited to be attending, exhibiting, and hosting a round table at the World Orphan Drug Congress (WODC), April 23–25, 2024. This year’s congress is at the Boston Convention and Exhibit Center.
Come by and see us at Booth 537!
Also, join us at Roundtable 06, on Wednesday, April 24, at 14:15, when our experts will discuss, “Meeting the Challenges of Fast-Track Approval for Orphan Drugs.” Senior Managing Scientist Amy Kimzey, PhD, DABT, will be joined by colleagues from Modality Solutions, EpidStrategies, and HEORStrategies to focus on optimal strategies for managing fast-track approval, from pre-clinical through clinical phases of development, regulatory support, and launch.
